Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | NAAA | Q02083 | 1/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | CCR2 | P41597 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21243365 | 0.90 | TP53 (0.50) | CYP1A2TP53CYP3A4MAPTLMNA | |
| SCHEMBL21243369 | 0.86 | HTT (0.39) | CYP1A2TP53CYP3A4MAPTPOLB | |
| SCHEMBL21243339 | 0.84 | CYP1A2 (0.37) | CYP1A2TP53CYP3A4MAPTPOLB | |
| SCHEMBL24276449 | 0.80 | TP53 (0.44) | TP53CYP3A4LMNANAAA | |
| SCHEMBL14422624 | 0.80 | TP53 (0.44) | TP53CYP3A4LMNANAAA | |
| SCHEMBL21243361 | 0.80 | TP53 (0.53) | TP53CYP3A4LMNA | |
| SCHEMBL21243363 | 0.79 | MAPT (0.43) | CYP1A2MAPTPOLBHPGDLMNA | |
| SCHEMBL21243330 | 0.79 | TP53 (0.49) | TP53CYP3A4MAPTLMNAHTT | |
| SCHEMBL21243359 | 0.79 | TP53 (0.60) | TP53CYP3A4HPGDLMNANAAA | |
| SCHEMBL12670574 | 0.78 | TP53 (0.55) | TP53CYP3A4LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10947472-B2 | Lubricant base oil for power transmission | NEW JAPAN CHEMICAL CO., LTD. (JP) | 2021-03-16 | — | — | US | disclosed |
| US-20190249103-A1 | LUBRICANT BASE OIL FOR POWER TRANSMISSION | NEW JAPAN CHEMICAL CO., LTD. (JP) | 2019-08-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10947472-B2 | Lubricant base oil for power transmission | DNAH12, DYNC1LI1, DYNC1LI2 | CYP1A2 3601/4885TP53 4733/4885CYP3A4 4194/4885 |
| US-20190249103-A1 | LUBRICANT BASE OIL FOR POWER TRANSMISSION | DNAH12, DYNC1LI1, DYNC1LI2 | CYP1A2 3601/4885TP53 4733/4885CYP3A4 4194/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.